Diagnos Historical Income Statement

ADK Stock

CAD 0.30 0.02 7.14%

Historical analysis of Diagnos income statement accounts such as Total Revenue of 185.9 K, Other Operating Expenses of 3.1 M or Research Development of 697.3 K can show how well Diagnos performed in making a profits. Evaluating Diagnos income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Diagnos's future profits or losses.

Cash Flow Balance Sheet Income Statement

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Diagnos latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Diagnos is a good buy for the upcoming year.

Net Income Gross Profit

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Diagnos. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

About Diagnos Income Statement Analysis

Diagnos Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Diagnos shareholders. The income statement also shows Diagnos investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Diagnos Income Statement Chart

At this time, Diagnos' Total Operating Expenses is fairly stable compared to the past year. Selling General Administrative is likely to climb to about 1.8 M in 2025, whereas Total Revenue is likely to drop slightly above 185.9 K in 2025.

Total Revenue Other Operating Expenses Research Development Total Operating Expenses

Total Revenue

Total revenue comprises all receipts Diagnos generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Diagnos. It is also known as Diagnos overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Total Operating Expenses

The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.

Most accounts from Diagnos' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Diagnos current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Diagnos. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

	2022	2024	2025 (projected)
Total Revenue	485.7K	195.7K	185.9K
Depreciation And Amortization	124.2K	142.8K	118.2K

Total Revenue Depreciation And Amortization

Diagnos income statement Correlations

	Depreciation And Amortization	Total Revenue	Gross Profit	Other Operating Expenses	Operating Income	Ebit	Research Development	Ebitda	Total Operating Expenses	Income Before Tax	Total Other Income Expense Net	Net Income	Income Tax Expense	Interest Expense	Cost Of Revenue	Selling General Administrative	Selling And Marketing Expenses	Discontinued Operations	Net Income From Continuing Ops	Net Interest Income	Reconciled Depreciation	Interest Income
Depreciation And Amortization		0.07	0.06	0.26	-0.26	-0.31	0.12	-0.21	0.3	-0.5	-0.28	-0.48	0.2	0.56	0.04	0.28	-0.06	0.28	-0.36	0.04	0.05	-0.02
Total Revenue	0.07		0.73	0.84	0.6	0.61	-0.34	0.61	0.28	-0.04	-0.4	-0.03	0.34	0.1	0.5	0.48	0.07	-0.54	0.0	-0.52	0.63	-0.37
Gross Profit	0.06	0.73		0.4	0.47	0.68	-0.35	0.69	0.72	0.15	-0.29	0.15	0.25	-0.24	-0.22	0.79	-0.36	-0.67	0.35	-0.52	0.64	-0.31
Other Operating Expenses	0.26	0.84	0.4		0.21	0.17	-0.16	0.15	0.18	-0.35	-0.41	-0.33	0.28	0.41	0.7	0.39	0.11	-0.41	-0.3	-0.57	0.64	-0.55
Operating Income	-0.26	0.6	0.47	0.21		0.89	-0.28	0.92	-0.07	0.32	-0.28	0.3	0.38	-0.24	0.28	-0.11	0.21	-0.21	0.13	0.02	-0.04	0.3
Ebit	-0.31	0.61	0.68	0.17	0.89		-0.42	0.97	0.11	0.36	-0.29	0.34	0.32	-0.31	0.03	0.15	0.07	-0.37	0.24	-0.19	0.17	0.12
Research Development	0.12	-0.34	-0.35	-0.16	-0.28	-0.42		-0.41	-0.22	0.03	0.2	0.02	-0.09	-0.2	-0.05	-0.18	0.0	-0.06	0.21	0.14	-0.1	0.09
Ebitda	-0.21	0.61	0.69	0.15	0.92	0.97	-0.41		0.19	0.34	-0.3	0.33	0.33	-0.27	0.02	0.15	0.08	-0.31	0.23	-0.13	0.12	0.15
Total Operating Expenses	0.3	0.28	0.72	0.18	-0.07	0.11	-0.22	0.19		-0.05	-0.18	-0.05	0.06	-0.13	-0.5	0.81	-0.65	-0.48	0.25	-0.45	0.52	-0.43
Income Before Tax	-0.5	-0.04	0.15	-0.35	0.32	0.36	0.03	0.34	-0.05		0.7	1.0	-0.61	-0.83	-0.25	-0.19	-0.09	-0.06	0.86	0.2	-0.14	0.31
Total Other Income Expense Net	-0.28	-0.4	-0.29	-0.41	-0.28	-0.29	0.2	-0.3	-0.18	0.7		0.72	-0.79	-0.5	-0.22	-0.22	-0.06	0.29	0.66	0.36	-0.25	0.27
Net Income	-0.48	-0.03	0.15	-0.33	0.3	0.34	0.02	0.33	-0.05	1.0	0.72		-0.64	-0.81	-0.24	-0.17	-0.09	-0.04	0.86	0.2	-0.13	0.3
Income Tax Expense	0.2	0.34	0.25	0.28	0.38	0.32	-0.09	0.33	0.06	-0.61	-0.79	-0.64		0.31	0.16	0.23	0.12	-0.14	-0.55	0.02	-0.01	0.05
Interest Expense	0.56	0.1	-0.24	0.41	-0.24	-0.31	-0.2	-0.27	-0.13	-0.83	-0.5	-0.81	0.31		0.46	-0.05	0.37	0.33	-0.87	-0.14	0.07	-0.21
Cost Of Revenue	0.04	0.5	-0.22	0.7	0.28	0.03	-0.05	0.02	-0.5	-0.25	-0.22	-0.24	0.16	0.46		-0.33	0.57	0.08	-0.47	-0.1	0.08	-0.14
Selling General Administrative	0.28	0.48	0.79	0.39	-0.11	0.15	-0.18	0.15	0.81	-0.19	-0.22	-0.17	0.23	-0.05	-0.33		-0.5	-0.6	0.2	-0.53	0.72	-0.5
Selling And Marketing Expenses	-0.06	0.07	-0.36	0.11	0.21	0.07	0.0	0.08	-0.65	-0.09	-0.06	-0.09	0.12	0.37	0.57	-0.5		0.42	-0.42	0.33	-0.34	0.18
Discontinued Operations	0.28	-0.54	-0.67	-0.41	-0.21	-0.37	-0.06	-0.31	-0.48	-0.06	0.29	-0.04	-0.14	0.33	0.08	-0.6	0.42		-0.34	0.79	-0.83	0.46
Net Income From Continuing Ops	-0.36	0.0	0.35	-0.3	0.13	0.24	0.21	0.23	0.25	0.86	0.66	0.86	-0.55	-0.87	-0.47	0.2	-0.42	-0.34		-0.02	0.15	0.13
Net Interest Income	0.04	-0.52	-0.52	-0.57	0.02	-0.19	0.14	-0.13	-0.45	0.2	0.36	0.2	0.02	-0.14	-0.1	-0.53	0.33	0.79	-0.02		-0.92	0.69
Reconciled Depreciation	0.05	0.63	0.64	0.64	-0.04	0.17	-0.1	0.12	0.52	-0.14	-0.25	-0.13	-0.01	0.07	0.08	0.72	-0.34	-0.83	0.15	-0.92		-0.65
Interest Income	-0.02	-0.37	-0.31	-0.55	0.3	0.12	0.09	0.15	-0.43	0.31	0.27	0.3	0.05	-0.21	-0.14	-0.5	0.18	0.46	0.13	0.69	-0.65

Click cells to compare fundamentals

Diagnos Account Relationship Matchups

Diagnos income statement Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Depreciation And Amortization	92.8K	105.8K	101.2K	124.2K	142.8K	118.2K
Total Revenue	267.1K	438.8K	485.7K	170.2K	195.7K	185.9K
Gross Profit	(347.5K)	(418.3K)	(306.8K)	(837.9K)	(754.1K)	(716.4K)
Other Operating Expenses	3.1M	2.6M	3.1M	2.8M	3.2M	3.1M
Operating Income	(2.0M)	(2.6M)	(2.2M)	(2.6M)	(2.3M)	(2.5M)
Ebit	(2.7M)	(2.0M)	(2.5M)	(2.6M)	(2.3M)	(2.5M)
Ebitda	(1.9M)	(2.4M)	(2.1M)	(2.5M)	(2.2M)	(2.3M)
Total Operating Expenses	1.9M	2.2M	2.7M	1.8M	2.0M	2.5M
Income Before Tax	(2.1M)	(2.6M)	(2.5M)	(3.1M)	(2.8M)	(2.9M)
Total Other Income Expense Net	264.3K	100.1K	12K	(519.8K)	(467.8K)	(444.4K)
Net Income	(2.1M)	(2.6M)	(2.5M)	(3.1M)	(2.8M)	(2.9M)
Income Tax Expense	432.9K	296.4K	153.9K	1.0	1.15	1.09
Interest Expense	32.2K	53.8K	278.9K	550.2K	632.7K	454.5K
Cost Of Revenue	614.6K	857.1K	792.5K	1.0M	1.2M	1.0M
Selling General Administrative	1.9M	2.2M	1.9M	1.8M	1.6M	1.8M
Net Income From Continuing Ops	(2.1M)	(2.6M)	(2.5M)	(3.1M)	(3.6M)	(3.8M)
Net Income Applicable To Common Shares	(3.8M)	(3.4M)	(2.1M)	(2.6M)	(2.3M)	(2.5M)
Net Interest Income	(32.2K)	(48.4K)	(271.1K)	(543.3K)	(624.8K)	(656.0K)
Reconciled Depreciation	87.4K	105.8K	101.2K	124.2K	111.8K	107.6K
Interest Income	18.5K	5.4K	7.8K	6.9K	6.2K	6.7K

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Diagnos Stock Analysis

When running Diagnos' price analysis, check to measure Diagnos' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Diagnos is operating at the current time. Most of Diagnos' value examination focuses on studying past and present price action to predict the probability of Diagnos' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Diagnos' price. Additionally, you may evaluate how the addition of Diagnos to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Diagnos Historical Income Statement

About Diagnos Income Statement Analysis

Diagnos Income Statement Chart

Total Revenue

Other Operating Expenses

Total Operating Expenses

Diagnos income statement Correlations

Diagnos Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Diagnos income statement Accounts

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for Diagnos Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Net Income	+ 1.0	Income Before Tax
Ebitda	+ 0.97	Ebit
Ebitda	+ 0.92	Operating Income
Ebit	+ 0.89	Operating Income
Net Income From Continuing Ops	+ 0.86	Income Before Tax
Net Income From Continuing Ops	+ 0.86	Net Income

Reconciled Depreciation	- 0.92	Net Interest Income
Net Income From Continuing Ops	- 0.87	Interest Expense
Reconciled Depreciation	- 0.83	Discontinued Operations
Interest Expense	- 0.83	Income Before Tax
Interest Expense	- 0.81	Net Income
Income Tax Expense	- 0.79	Total Other Income Expense Net